Table 2.
Study | Source of cases | Study design type | Disease type | Definition of disease | Detection of HCMV | HCMV+
|
HCMV−
|
||
---|---|---|---|---|---|---|---|---|---|
Steroid resistant/refractory | Total | Steroid resistant/refractory | Total | ||||||
Lévêque et al,24 2010 | France | Case | IBD | WHO | DNA | 0 | 5 | 8 | 29 |
Domènech et al,13 2008 | Spain | Case | UC | WHO | IgG | 13 | 29 | 6 | 14 |
Iida et al,3 2013 | Japan | Case | UC | WHO | IgG IgM |
62 | 141 | 20 | 46 |
Wada et al,25 2003 | Japan | Case | UC | WHO | pp65 | 13 | 16 | 9 | 31 |
Kambham et al,26 2004 | USA | Case | UC | WHO | CMV inclusions IE |
12 | 13 | 28 | 67 |
Maconi et al,27 2005 | Italy | Case | UC | WHO | IE | 15 | 17 | 40 | 60 |
Kuwabara et al,19 2007 | Japan | Case | IBD | WHO | IE | 13 | 14 | 2 | 8 |
Maher et al,28 2009 | Egypt | Case | IBD | WHO | IgM IE |
8 | 9 | 15 | 63 |
Criscuoli et al,29 2011 | Italy | Case | UC | WHO | CMV inclusions IE DNA Pp65 |
6 | 28 | 11 | 57 |
Mccurdy et al,30 2015 | USA | Case | IBD | WHO | CMV inclusions IE |
40 | 68 | 61 | 202 |
Ciccocioppo et al,20 2015 | Italy | Case | IBD | WHO | IE | 4 | 9 | 13 | 31 |
Ciccocioppo et al,34 2016 | Italy | Case | IBD | WHO | IE | 25 | 51 | 0 | 13 |
Cottone et al,31 2001 | Italy | Case | IBD | WHO | DNA | 7 | 7 | 12 | 55 |
Criscuoli et al,31 2004 | Italy | Case | IBD | WHO | pp65 DNA |
4 | 9 | 8 | 33 |
Criscuoli et al,21 2015 | Italy | Case | UC | WHO | CMV inclusions IE DNA pp65 |
5 | 11 | 7 | 13 |
Kim et al,35 2012 | Korea | Case | UC | WHO | DNA | 14 | 31 | 7 | 41 |
Ormeci et al,33 2016 | Turkey | Case | IBD | WHO | DNA | 8 | 13 | 5 | 72 |
Abbreviations: HCMV, human cytomegalovirus; IBD, inflammatory bowel disease; IE, immediate-early; CMV, cytomegalovirus; UC, ulcerative colitis; WHO, World Health Organization.